Session Details

U029 GI Skin: Cutaneous Manifestations of Gastrointestinal Inflammatory Disorders

Sat, Mar 20, 7:30 AM - 8:30 AM
1 CME Available Focus Session

DESCRIPTION

This session focuses on the presentation, diagnosis, and multi-disciplinary management of cutaneous manifestations of gastrointestinal inflammatory conditions. Inflammatory bowel disease impacts the skin with specific, reactive, and associated conditions. In addition, other inflammatory conditions may impact both the skin and GI tract including dermatoses associated with stomas. This session is geared toward general dermatologists who are evaluating and managing these patients in conjunction with the gastroenterology team and collaborating on their care.

LEARNING OBJECTIVES

1.

Recognize and diagnose cutaneous manifestations of inflammatory gastrointestinal conditions

2.

Evaluate patients with cutaneous manifestations of inflammatory gastrointestinal conditions and recognize when and how to initiate an evaluation for gastrointestinal disease based on the cutaneous presentation.

3.

Collaborate with multi disciplinary providers to treat patients' cutaneous manifestations in the context of their gastrointestinal condition and treatment plan.

SCHEDULE

7:30 AM

Introduction

Afsaneh Alavi, MD, FAAD, Alexandra Coromilas, MD, FAAD

7:32 AM

Cutaneous Crohn Disease

Alexandra Coromilas, MD, FAAD

7:42 AM

HS and Perianal Crohn Disease

Mika Takaichi, MD, PhD

7:52 AM

Neutrophilic Dermatoses in IBD

Bridget Shields, MD, FAAD

8:02 AM

Stoma Skin: What Every Dermatologist Should Recognize

Anagha Bangalore Kumar, MD, MBBS, FAAD

8:12 AM

Treatment-Associated Skin Disease in IBD

Alexandra P. Charrow, MD, FAAD

8:22 AM

Discussion

DIRECTOR

Afsaneh Alavi, MD, FAAD

Afsaneh Alavi, MD, FAAD

CO-DIRECTOR

Alexandra Coromilas, MD, FAAD

Alexandra Coromilas, MD, FAAD

SPEAKERS

Anagha Bangalore Kumar, MD, MBBS, FAAD

Anagha Bangalore Kumar, MD, MBBS, FAAD

Alexandra P. Charrow, MD, FAAD

Alexandra P. Charrow, MD, FAAD

Bridget Shields, MD, FAAD

Bridget Shields, MD, FAAD

Mika Takaichi, MD, PhD

Mika Takaichi, MD, PhD

Department of Dermatology Graduate School of Medicine, Osaka Metropolitan University Osaka, Japan

DISCLOSURES

Afsaneh Alavi, MD, FAAD

AbbVie – Advisory Board(Honoraria); Almirall – Data Safety Monitoring Board(Fees); Alumis – Advisory Board(Honoraria); Avalo – Consultant (1099 relationship)(Fees); Blueprint Medicines – Advisory Board(Honoraria); Cantargia – Consultant (1099 relationship)(Fees); Dermatology Times (MMM MultiMedia Medical, LLC) – Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); InflaRx – Data Safety Monitoring Board(Honoraria); Leo Foundation – Advisory Board(Honoraria); MoonLake Immunotherapeutics – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Oruka – Data Safety Monitoring Board(Honoraria); Sanofi – Advisory Board(Honoraria); Shattuck Labs – Data Safety Monitoring Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); Zura Bio – Data Safety Monitoring Board(Honoraria);

Anagha Bangalore Kumar, MD, MBBS, FAAD

No financial relationships exist with ineligible companies.

Alexandra P. Charrow, MD, FAAD

Avalo – Consultant (1099 relationship)(Fees); Dermatology Foundation – Investigator(Grants/Research Funding); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Fees), Investigator(No Compensation Received); Insmed – Investigator(No Compensation Received); Insmed Incorporated – Investigator(No Compensation Received); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(No Compensation Received); Sonoma Biotherapeutics – Investigator(No Compensation Received); UCB Pharma – Advisory Board(Honoraria); Wedbush Securities – Consultant (1099 relationship)(Honoraria);

Alexandra Coromilas, MD, FAAD

No financial relationships exist with ineligible companies.

Bridget Shields, MD, FAAD

Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria); UpToDate, Inc – Other(Honoraria);

Mika Takaichi, MD, PhD

No financial relationships exist with ineligible companies.